Tricida Inc

Tricida Inc is a cutting-edge pharmaceutical company that specializes in developing and commercializing innovative therapies to meet the unmet medical needs of patients. Their flagship product, TRC101, is a non-absorbed, orally-administered polymer that effectively treats metabolic acidosis, a common condition associated with chronic kidney disease. Tricida's ultimate goal is to enhance the quality of life for patients with chronic kidney disease by creating therapies that target the root causes of their conditions. The company is committed to advancing the science of kidney disease and collaborating with healthcare providers to improve patient outcomes. With its headquarters in South San Francisco, California, Tricida boasts a team of seasoned professionals who are dedicated to bringing new treatments to the market.